Clinical trial

Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor

NCT02069158

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention PF-05212384 Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Paclitaxel Normalized identity: paclitaxelView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Carboplatin Normalized identity: carboplatinView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-04-01

PhasePHASE1

Conditions

Breast Cancerverified · MONDO: breast cancer

NSCLCverified · MONDO: non-small cell lung carcinoma

Ovary Cancerverified · MONDO: ovarian cancer

Endometrial Cancerverified · MONDO: endometrial cancer

Small Cell Lung Cancer (SCLC)unresolved

Head and Neck (HNSCC)unresolved

Interventions

PF-05212384DRUG

PaclitaxelDRUG · verified · RxNorm: paclitaxel

CarboplatinDRUG · verified · RxNorm: carboplatin

Sponsors & collaborators

Cristiana Sessalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02069158 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.